Patient Recruitment Dodges Older Adults to Their Detriment

Despite representing the largest market for new and existing medications, a recent study by the UK-based International Longevity Centre (ILC) finds that adults over 60 are starkly underrepresented or outright excluded from clinical trials. Costs are commonly credited for this disparity, which imperils health outcomes for older adults.

According to Phil Taylor, “Acknowledging that situation, the FDA recently published proposals to require diversity plans from researchers in order for new trials to be approved, while in the UK the MHRA has also announced legislative changes on trial applications that include a pledge to provide guidance on achieving diversity in studies.”

To read more, click here.

(Source: PharmaPhorum, April 18^th, 2023)